![Francisco Carlos Marques de Freitas](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Francisco Carlos Marques de Freitas
Direttore operativo presso BIOMM S.A.
Profilo
Francisco Carlos Marques de Freitas is currently the Chief Operating Officer at BIOMM SA since 2014.
Previously, he worked at Biobras SA from 1995 to 2002 as a Member-Executive Board.
Mr. Marques de Freitas completed his undergraduate degree at the University of Pennsylvania in 1992 and also holds an undergraduate degree from Universidade Federal de Minas Gerais, which he obtained in 1977.
Posizioni attive di Francisco Carlos Marques de Freitas
Società | Posizione | Inizio |
---|---|---|
BIOMM S.A. | Direttore operativo | 20/02/2014 |
Precedenti posizioni note di Francisco Carlos Marques de Freitas
Società | Posizione | Fine |
---|---|---|
Biobras SA
![]() Biobras SA Pharmaceuticals: MajorHealth Technology Part of Novo Nordisk A/S, Biobras SA is a Brazilian company that manufactures diabetes products. The company is based in Montes Claros, Brazil. The company was founded by Guilherme Caldas Emrich. Biobras was acquired by Novo Nordisk A/S on November 19, 2002 for $15.70 million. | Corporate Officer/Principal | 01/01/2002 |
Formazione di Francisco Carlos Marques de Freitas
Universidade Federal de Minas Gerais | Undergraduate Degree |
University of Pennsylvania | Undergraduate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
Società quotate in Borsa | 1 |
---|---|
BIOMM S.A. | Health Technology |
Aziende private | 1 |
---|---|
Biobras SA
![]() Biobras SA Pharmaceuticals: MajorHealth Technology Part of Novo Nordisk A/S, Biobras SA is a Brazilian company that manufactures diabetes products. The company is based in Montes Claros, Brazil. The company was founded by Guilherme Caldas Emrich. Biobras was acquired by Novo Nordisk A/S on November 19, 2002 for $15.70 million. | Health Technology |
- Borsa valori
- Insiders
- Francisco Carlos Marques de Freitas